This study is currently not recruiting participants.

Evaluation of the Spectra Optia Aphaeresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to determine if stem cells harvested by an investigational apheresis device, the Spectra Optia Apheresis System, are able to rescue damaged bone marrow as well as stem cells harvested by similar devices that the Food and Drug

Detailed description of study

The purpose of this study is to determine if stem cells harvested by an investigational apheresis device, the Spectra Optia Apheresis System, are able to rescue damaged bone marrow as well as stem cells harvested by similar devices that the Food and Drug

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Myeloma
  • Age: 18 years - 100 years
  • Gender: All
Updated on 16 Sep 2011. Study ID: 1106006083 (1102-02)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team